- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00820833
Effect of Formula on Growth of Infants From Overweight or Obese Mothers
March 25, 2015 updated by: Société des Produits Nestlé (SPN)
Effect of Protein Levels and Caloric Density on the Growth of Formula Fed Infants From Overweight or Obese Mothers
The purpose of this study is to determine whether infants, from overweight or obese mothers, fed a formula with proteins and calories different than a standard infant formula have a different growth
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
230
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Temuco, Chile
- Departamento de Medicina Interna, University de la Frontera
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
3 months to 1 year (Child)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- healthy newborn infant
- birth weight between 2500g and 4800g
- singleton birth
- mother's BMI before pregnancy was between 26 and 25
- for the breastfeeding group: mother has elected to exclusively breastfeed her baby from birth to at least 6 months of age
- for the formula groups: mother has elected to exclusively formula feed her baby from 3 to 6 months of age
- having obtained signed informed consent of legal representative
Exclusion Criteria:
- body weight smaller than 5th percentile for that gestational age
- newborn whose mother has diabetes
- newborn whose mother has a drug dependence during pregnancy
- newborn currently participating in another trial
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: 1
Standard infant formula
|
standard infant formula given from 3 to 12 months of age, as per standard requirement
|
|
Experimental: 2
Test formula
|
Test formula with different protein and calorie content than standard formula, given from 3 to 12 months of age.
As per standard requirement.
|
|
No Intervention: 3
Breastfeeding reference group
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
mean weight gain
Time Frame: 3 months
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
blood test assessments; body composition, bone density
Time Frame: 9 months
|
9 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Jaime Inostroza, PhD, Universidad de La Frontera
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2007
Primary Completion (Actual)
June 1, 2010
Study Completion (Actual)
December 1, 2014
Study Registration Dates
First Submitted
January 8, 2009
First Submitted That Met QC Criteria
January 8, 2009
First Posted (Estimate)
January 12, 2009
Study Record Updates
Last Update Posted (Estimate)
March 26, 2015
Last Update Submitted That Met QC Criteria
March 25, 2015
Last Verified
December 1, 2014
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 05.29.INF
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infant Nutrition
-
Pennington Biomedical Research CenterNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingInfant Development | Infant OvernutritionUnited States
-
University of ManitobaJohns Hopkins University; University Health Network, Toronto; University of California... and other collaboratorsActive, not recruitingMaternal Health | Infant Growth | Infant NutritionCanada
-
Augusta UniversityActive, not recruiting
-
Arkansas Children's Hospital Research InstituteNot yet recruitingMaternal Health | Infant Nutrition | Maternal Nutrition | Pediatric NutritionUnited States
-
Jennewein Biotechnologie GmbHAnalyze & RealizeCompletedInfant NutritionItaly, Germany, Spain
-
Ludwig-Maximilians - University of MunichHiPP GmbH & Co. Vertrieb KGCompletedInfant NutritionGermany, Serbia
-
Sun Yat-sen UniversityEnzymotecCompletedInfant NutritionChina
-
NestléCompleted
-
Mead Johnson NutritionInstituto de Nutricion y Tecnologia de los Alimentos (INTA)Completed
Clinical Trials on standard infant formula
-
Société des Produits Nestlé (SPN)Completed
-
Société des Produits Nestlé (SPN)University College, LondonCompletedGrowth | Infant FormulaUnited Kingdom
-
Biostime (Guangzhou) Health Products LimitedBioFortis; Merieux NutriSciences (China)Active, not recruiting
-
Laboratorios OrdesaUnknownInfant DevelopmentSpain
-
Ludwig-Maximilians - University of MunichHiPP GmbH & Co. Vertrieb KGCompletedInfant NutritionGermany, Serbia
-
FrieslandCampinaTerminated
-
NestléNational University Hospital, SingaporeCompleted